CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity

There are many inhibitory mechanisms that function at the cellular and molecular levels to maintain tolerance. Despite this, self-reactive clones escape regulatory mechanisms and cause autoimmunity in certain circumstances. We hypothesized that the same mechanisms that permit T cells to expand during homeostatic proliferation may inadvertently promote autoimmunity under certain conditions. One major homeostatic cytokine is IL-7, and studies have linked it or its receptor to the development of multiple sclerosis and other autoimmune diseases. We show in a model of β-islet cell self-reactivity that the transfer of activated autoreactive CD4 T cells can prime and expand endogenous autoreactive CD8 T cells in a CD28- and CD40-dependent manner through the licensing of dendritic cells. Despite this, mice do not develop diabetes. However, the provision of exogenous IL-7 or the physiological production of IL-7 associated with lymphopenia was able to profoundly promote the expansion of self-reactive clones even in the presence of regulatory T cells. Autoimmune diabetes rapidly ensued with CD4 help and the subsequent activation of CD8 T cells, which contributed to disease progression. With the advent of many biologicals targeting TNFα, IL-6, and IL-1 and their effective use in the treatment of autoimmune diseases, we propose that IL-7 and its receptor may be promising targets for biological agents in the treatment of autoimmunity.

[1]  P. Santamaria,et al.  IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. , 2000, The Journal of clinical investigation.

[2]  D. Pardoll,et al.  Cd40-Independent Pathways of T Cell Help for Priming of Cd8+ Cytotoxic T Lymphocytes , 2000, The Journal of experimental medicine.

[3]  N. Sarvetnick,et al.  Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity , 2004, Cell.

[4]  H. Pircher,et al.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen , 1989, Nature.

[5]  B. Rocha,et al.  A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory , 2002, Science.

[6]  C. Kurts,et al.  CD4+ T Cell Help Impairs CD8+ T Cell Deletion Induced by Cross-presentation of Self-Antigens and Favors Autoimmunity , 1997, The Journal of experimental medicine.

[7]  P. Santamaria,et al.  IL-1α, IL-1β, and IFN-γ mark β cells for Fas-dependent destruction by diabetogenic CD4+ T lymphocytes , 2000 .

[8]  E. Proietti,et al.  Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. , 1998, The Journal of clinical investigation.

[9]  B. Chauffert,et al.  CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative , 2004, European journal of immunology.

[10]  M. Bevan,et al.  Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help , 2003, Science.

[11]  H. Nakajima,et al.  Cell‐mediated transfer of collagen‐induced arthritis in mice and its application to the analysis of the inhibitory effects of interferon‐gamma and cyclophosphamide , 1993, Clinical and experimental immunology.

[12]  C. Benoist,et al.  TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets , 2007, The Journal of experimental medicine.

[13]  Gabrielle T Belz,et al.  Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity , 2004, Nature Immunology.

[14]  T. Fry,et al.  Autoimmunity during lymphopenia: a two-hit model. , 2006, Clinical immunology.

[15]  L. Bracci,et al.  Cyclophosphamide Enhances the Antitumor Efficacy of Adoptively Transferred Immune Cells through the Induction of Cytokine Expression, B-Cell and T-Cell Homeostatic Proliferation, and Specific Tumor Infiltration , 2007, Clinical Cancer Research.

[16]  Susumu Tonegawa,et al.  High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice , 1994, Cell.

[17]  J. Bijlsma,et al.  Interleukin-7 induced immunopathology in arthritis , 2006, Annals of the rheumatic diseases.

[18]  S. Miller,et al.  Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler's virus infection. , 2001, Journal of autoimmunity.

[19]  H. Pircher,et al.  Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice , 1991, Cell.

[20]  E. Wherry,et al.  Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection , 2007, The Journal of experimental medicine.

[21]  Urs Christen,et al.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes , 2003, Nature.

[22]  Stephen P. Schoenberger,et al.  T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.

[23]  Richard A. Flavell,et al.  Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.

[24]  Polly Matzinger,et al.  A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell , 1998, Nature.

[25]  R. Flavell,et al.  Helper Requirements for Generation of Effector CTL to Islet β Cell Antigens1 , 2004, The Journal of Immunology.

[26]  Hao Shen,et al.  Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory , 2003, Science.

[27]  L. Hood,et al.  Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity , 1993, Cell.

[28]  R. Brodsky.  High-dose cyclophosphamide for aplastic anemia and autoimmunity , 2002, Current opinion in oncology.

[29]  R. Zinkernagel,et al.  Virus‐specific major MHC class II‐restricted TCR‐transgenic mice: effects on humoral and cellular immune responses after viral infection , 1998, European journal of immunology.

[30]  T. Mak,et al.  TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice. , 2007, The Journal of clinical investigation.

[31]  P. Matzinger,et al.  A fail-safe mechanism for maintaining self-tolerance , 1992, The Journal of experimental medicine.

[32]  H. Fujiwara,et al.  The development of dermatitis infiltrated by γδ T-cells in IL-7 transgenic mice , 1993 .

[33]  T. Mak,et al.  TNF-α is critical for antitumor but not antiviral T cell immunity in mice , 2007 .

[34]  I. Cohen,et al.  Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway. , 1999, Journal of autoimmunity.

[35]  H. Harbo,et al.  Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. , 2007, Nature genetics.

[36]  S. Rosenberg,et al.  Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells , 2005, The Journal of experimental medicine.

[37]  F. Sallusto,et al.  Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia , 2005, The Journal of experimental medicine.

[38]  Eric S. Lander,et al.  Genetic dissection of autoimmune type I diabetes in the BB rat , 1992 .

[39]  T. Hibi,et al.  Interleukin 7 Transgenic Mice Develop Chronic Colitis with Decreased Interleukin 7 Protein Accumulation in the Colonic Mucosa , 1998, The Journal of experimental medicine.

[40]  E. S. St. Clair,et al.  New therapeutics in rheumatoid arthritis. , 2006, Rheumatic diseases clinics of North America.

[41]  R. Flavell,et al.  Helper requirements for generation of effector CTL to islet beta cell antigens. , 2004, Journal of immunology.

[42]  A. Cooke,et al.  Cyclophosphamide-Induced Type-1 Diabetes in the NOD Mouse Is Associated with a Reduction of CD4+CD25+Foxp3+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[43]  K. Tsuchiya,et al.  IL-7 Is Essential for the Development and the Persistence of Chronic Colitis1 , 2007, The Journal of Immunology.

[44]  Pamela S. Ohashi,et al.  T-cell signalling and autoimmunity: molecular mechanisms of disease , 2002, Nature Reviews Immunology.

[45]  C. Benoist,et al.  Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.

[46]  T. Fry,et al.  Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. , 2005, The Journal of clinical investigation.

[47]  H. Fujiwara,et al.  The development of dermatitis infiltrated by gamma delta T cells in IL-7 transgenic mice. , 1993, International immunology.

[48]  K. Haskins,et al.  Induction of Diabetes in Nonobese Diabetic Mice by Th2 T Cell Clones from a TCR Transgenic Mouse1 , 2000, The Journal of Immunology.